Listar por autor "Bodoque-García, Ana"

Preguntas frecuentes Manual de uso Contacto/Sugerencias

Mostrando ítems 1-2 de 2

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

Segovia-Zafra, Antonio; Villanueva-Paz, Marina; Serras, Ana Sofía; Matilla-Cabello, Gonzalo; Bodoque-García, Ana; Di Zeo-Sánchez, Daniel Enrique; Niu, Hao; Álvarez-Álvarez, Ismael; Sanz-Villanueva, Laura; Godec, Sergej; Milisav, Irina; Bagnaninchi, Pierre; Andrade, Raúl J.; Lucena, M. Isabel; Fernandez-Checa, J.C.; Cubero, Francisco Javier; Paiva Miranda, Joana; Nelson, Leonard J.[et al.] (Elsevier, 2024)

Background & Aims Idiosyncratic drug-induced liver injury (DILI) is a complex and unpredictable event caused by drugs, and herbal or dietary supplements. Early identification of human hepatotoxicity at preclinical stages ...
Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions

Cueto Sánchez, Alejandro José; Di Zeo-Sánchez, Daniel Enrique; Segovia-Zafra, Antonio; Matilla-Cabello, Gonzalo; Bodoque-García, Ana; Lucena-González, María Isabel; Villanueva-Paz, Marina[et al.] (Open Exploration, 2023-04-26)

The late event onset of a fraction of idiosyncratic drug-induced liver injury (DILI) cases and the link observed by genome-wide association studies (GWASs) of certain human leucocyte antigen (HLA) alleles with DILI due to ...